Aspira Pathlab & Diagnostics Stock

Aspira Pathlab & Diagnostics Debt 2024

Aspira Pathlab & Diagnostics Debt

13.98 INR

Ticker

540788.BO

ISIN

INE500C01017

In 2024, Aspira Pathlab & Diagnostics's total debt was 13.98 INR, a -38.65% change from the 22.78 INR total debt recorded in the previous year.

Aspira Pathlab & Diagnostics Aktienanalyse

What does Aspira Pathlab & Diagnostics do?

Aspira Pathlab & Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Aspira Pathlab & Diagnostics's Debt Structure

Aspira Pathlab & Diagnostics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Aspira Pathlab & Diagnostics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Aspira Pathlab & Diagnostics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Aspira Pathlab & Diagnostics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Aspira Pathlab & Diagnostics stock

What is the debt of Aspira Pathlab & Diagnostics this year?

Aspira Pathlab & Diagnostics has a debt level of 13.98 INR this year.

What was the debt of Aspira Pathlab & Diagnostics compared to the previous year?

The debt of Aspira Pathlab & Diagnostics has increased by -38.65% compared to the previous year dropped.

What are the consequences of high debt for investors in Aspira Pathlab & Diagnostics?

High debt can pose a risk for investors of Aspira Pathlab & Diagnostics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Aspira Pathlab & Diagnostics?

Low debt means that Aspira Pathlab & Diagnostics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Aspira Pathlab & Diagnostics affect the company?

An increase in debt of Aspira Pathlab & Diagnostics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Aspira Pathlab & Diagnostics affect the company?

A reduction in debt of Aspira Pathlab & Diagnostics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Aspira Pathlab & Diagnostics?

Some factors that can influence the debt of Aspira Pathlab & Diagnostics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Aspira Pathlab & Diagnostics so important for investors?

The debts of Aspira Pathlab & Diagnostics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Aspira Pathlab & Diagnostics take to change the debt?

To change the debt, Aspira Pathlab & Diagnostics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Aspira Pathlab & Diagnostics pay?

Over the past 12 months, Aspira Pathlab & Diagnostics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aspira Pathlab & Diagnostics is expected to pay a dividend of 0 INR.

What is the dividend yield of Aspira Pathlab & Diagnostics?

The current dividend yield of Aspira Pathlab & Diagnostics is .

When does Aspira Pathlab & Diagnostics pay dividends?

Aspira Pathlab & Diagnostics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aspira Pathlab & Diagnostics?

Aspira Pathlab & Diagnostics paid dividends every year for the past 0 years.

What is the dividend of Aspira Pathlab & Diagnostics?

For the upcoming 12 months, dividends amounting to 0 INR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aspira Pathlab & Diagnostics located?

Aspira Pathlab & Diagnostics is assigned to the '-' sector.

Wann musste ich die Aktien von Aspira Pathlab & Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aspira Pathlab & Diagnostics from 9/22/2024 amounting to 0 INR, you needed to have the stock in your portfolio before the ex-date on 9/22/2024.

When did Aspira Pathlab & Diagnostics pay the last dividend?

The last dividend was paid out on 9/22/2024.

What was the dividend of Aspira Pathlab & Diagnostics in the year 2023?

In the year 2023, Aspira Pathlab & Diagnostics distributed 0 INR as dividends.

In which currency does Aspira Pathlab & Diagnostics pay out the dividend?

The dividends of Aspira Pathlab & Diagnostics are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Aspira Pathlab & Diagnostics

Our stock analysis for Aspira Pathlab & Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aspira Pathlab & Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.